TransCode Therapeutics (RNAZ) Earnings Date, Estimates & Call Transcripts $0.42 -0.09 (-17.51%) Closing price 04:00 PM EasternExtended Trading$0.41 -0.01 (-2.01%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TransCode Therapeutics Earnings Summary Upcoming Q3 Earnings DateMay. 21EstimatedConsensus EPS (Aug. 14) -$19.14 Actual EPS (Aug. 14) -$24.42 Missed By -$5.28 TransCode Therapeutics released Q2 2024 earnings on August 14, 2024, reporting an EPS of -$24.42, which missed the consensus estimate of -$19.14 by $5.28. With a trailing EPS of $0.00, TransCode Therapeutics' earnings are expected to grow next year, from ($4.76) to ($4.37) per share. Q2 2024 Earnings ResourcesQ2 2024 Earnings ReportRNAZ Upcoming EarningsTransCode Therapeutics' next earnings date is estimated for Wednesday, May 21, 2025, based on past reporting schedules. Get TransCode Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on TransCode Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataRNAZ Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. TransCode Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$2.00-$2.00-$2.00Q2 20251-$0.31-$0.31-$0.31Q3 20251-$0.33-$0.33-$0.33Q4 20251-$0.36-$0.36-$0.36 TransCode Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/21/2025(Estimated)--------8/14/2024Q2 2024-$19.14-$24.42 -$5.28-$0.74--5/15/2024Q1 2024-$23.10-$21.45+$1.65-$0.65--11/14/2023Q3 2023-$1,980.00-$2,217.60 -$237.60-$1.68--8/14/2023Q2 2023-$4,474.80-$4,342.80+$132.00-$3.29--5/15/2023Q1 2023--$8,712.00 -$8,712.00-$6.60-- TransCode Therapeutics Earnings - Frequently Asked Questions When is TransCode Therapeutics's earnings date? TransCode Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 21st, 2025 based off last year's report dates. Learn more on RNAZ's earnings history. Did TransCode Therapeutics beat their earnings estimates last quarter? In the previous quarter, TransCode Therapeutics (NASDAQ:RNAZ) missed the analysts' consensus estimate of ($19.14) by $5.28 with a reported earnings per share (EPS) of ($24.42). Learn more on analysts' earnings estimate vs. RNAZ's actual earnings. How much profit does TransCode Therapeutics generate each year? TransCode Therapeutics (NASDAQ:RNAZ) has a recorded net income of -$18.55 million. RNAZ has generated $0.00 earnings per share over the last four quarters. What is TransCode Therapeutics's EPS forecast for next year? TransCode Therapeutics's earnings are expected to grow from ($4.76) per share to ($4.37) per share in the next year. More Earnings Resources from MarketBeat Related Companies Opus Genetics Earnings Rein Therapeutics Earnings Shattuck Labs Earnings Werewolf Therapeutics Earnings SCYNEXIS Earnings Eliem Therapeutics Earnings Estrella Immunopharma Earnings Celularity Earnings Lantern Pharma Earnings Aadi Bioscience Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Is Reddit Stock a Buy, Sell, or Hold After Earnings Release?Warning or Opportunity After Super Micro Computer's EarningsAmazon Earnings: 2 Reasons to Love It, 1 Reason to Be CautiousRocket Lab Braces for Q1 Earnings Amid Soaring ExpectationsMeta Takes A Bow With Q1 Earnings - Watch For Tariff Impact in Q2Palantir Earnings: 1 Bullish Signal and 1 Area of ConcernVisa Q2 Earnings Top Forecasts, Adds $30B Buyback Plan This page (NASDAQ:RNAZ) was last updated on 5/5/2025 by MarketBeat.com Staff From Our PartnersMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredU.S. Stock Market Now on Verge of CollapseThe last time the U.S. economy looked like this, stocks didn't move for 16 years... And many investors lost...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TransCode Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TransCode Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RNAZ Stock Free RNAZ Stock Alerts